OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at Kinnate Biopharma Inc. (KNTE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 5, 2023, OrbiMed Genesis GP LLC's relationship to Kinnate Biopharma Inc. (KNTE) is Director,TenPercentOwner, and currently has 1,368,339 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KNTE insiders.

Data Source: SEC.
OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions of KNTE Common Stock
OrbiMed Genesis GP LLC - Insider Non-Derivative Transactions at KNTE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 6, 2023 P -- (Common Stock) 490511 2.82 1368338
May 6, 2023 P -- (Common Stock) 490512 2.82 1368339
May 5, 2023 P -- (Common Stock) 83459 2.75 877827
May 5, 2023 P -- (Common Stock) 312991 2.75 4738453